Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Change in Accured Expenses (2021 - 2026)

BioScience Health Innovations has reported Change in Accured Expenses over the past 6 years, most recently at $14824.0 for Q1 2026.

  • Quarterly Change in Accured Expenses changed 0.45% to $14824.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2031.0 through Mar 2026, down 89.23% year-over-year, with the annual reading at $1964.0 for FY2025, 56.77% down from the prior year.
  • Change in Accured Expenses was $14824.0 for Q1 2026 at BioScience Health Innovations, up from $1271.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $14824.0 in Q1 2026 and troughed at -$17814.0 in Q3 2025.
  • The 5-year median for Change in Accured Expenses is $1271.0 (2025), against an average of $2050.9.
  • The largest YoY upside for Change in Accured Expenses was 3471.43% in 2025 against a maximum downside of 3662.8% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at -$221.0 in 2022, then surged by 756.11% to $1450.0 in 2023, then soared by 140.9% to $3493.0 in 2024, then tumbled by 63.61% to $1271.0 in 2025, then skyrocketed by 1066.33% to $14824.0 in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Change in Accured Expenses are $14824.0 (Q1 2026), $1271.0 (Q4 2025), and -$17814.0 (Q3 2025).